Objective/Introduction The Revised Illness Perception Questionnaire adapted for Work Disability (IPQR-WD) is an adaptation of Illness Perception Questionnaire-Revised: the most used and most comprehensive tool for measuring illness perceptions. Evaluating…
Objective Among pelvitrochanteric muscles, the internal obturator muscle is implicated in some pain projected at the buttock or perineum. Even though the pathophysiology is not completely understood, its responsibility is…
Objective/Introduction The body image refers to the conscious representation of our own body. It can be modulated by various sensory manipulations and can also be disturbed in people with chronic…
Objective Our study aims to assess the prevalence and risk factors of low back pain occurred in health care workers in a Lebanese Hospital, and the impact of gestural and…
Objective Complex regional pain syndrome (CRPS) is an invalidating chronic condition subsequent to peripheral lesions, with frequent therapeutic failure. There is growing consensus for a central contribution to CRPS. However,…
Objective Central neuropathic pain is common among neurological patients. Drug therapy has high pharmacoresistance and some GABAergic agents can be detrimental to the recovery process. Alternative therapies include neuromodulation techniques,…
Objective The musculotendinous retractions are common complications of central neurological damage with consequences for comfort and function. Treatment of uncomfortable retractions is often surgical, mainly based on tendon gestures. The…
Objective Botulinum toxins are often prescribed in aftercare and neurological rehabilitation services. In our hospital, they are exponentially used in the treatment of spasticity. The objective of this study is…
Objective Hypermetric tremors, i.e. of cerebellar origin (essential tremor, cerebellar stroke or tumor, multiple sclerosis, hereditary spinocerebellar ataxias), directly relate to iterative hypermetria by delayed antagonist correction at each movement…
Objective The therapeutic effects of intramuscular injections of botulinum toxin-type A on spasticity can be largely explained by its blocking action at the neuromuscular junction. BTx-A is assumed also to…
